Answer :
Word Count : 325

In the field of Drugs Regulatory Affairs, there are specific legal provisions related to biological products that distinguish them from conventional pharmaceuticals. Biological products, also known as biologics, are complex medicines derived from living organisms or their products, including vaccines, monoclonal antibodies, gene therapies, and cellular therapies. These products require unique regulatory considerations due to their inherent complexity and the potential for variations in manufacturing processes.

One of the key special provisions in law related to biological products is the Biologics Price Competition and Innovation Act (BPCIA) in the United States. Enacted as part of the Affordable Care Act (ACA) in 2010, the BPCIA established an abbreviated pathway for the approval of biosimilar and

________ ____ _____ _______ _______ _____ ___ ____ ______ ____ ______ ______.
_________ ________ ____ _______ _______ ________.
__________ _________ ___ ____ ___ ____ _______ ________ __________ _____.
______ ________ ______ __________ ___ ________ ___ _______ _________ ____ _______ _________.
______ ____ _________ ______ _______ _____.
________ ____ ________ _________ ___ ___ ________ ______.
_______ _________ ______ ____ ________ ___ __________.
__________ __________ ____ ___ ____ ______ _____.
__________ __________ ______ ____ ____.
_____ _______ _________ _____ _______ ____ ________ ___ __________ __________ _________ _______.
___ _________ ________ ________ _________ _________ ___.
_________ ____ _______ _____ ____ ___ ______.
___ __________ _______ _____ ______ __________ ____ ________ ____ _________ ________.
____ ____ ___ ______ _________ __________ ____ _________.
_____ _______ __________ ________ _____.
__________ ___ _______ _______ ____ _____ ___ _____ ____.
_______ ______ ______ _________ __________ __________.
________ ____ ___ ___ _________ __________ _____ __________ _______.
___ ___ ________ ________ _______ ____ __________ ____ _____ _______ ____ ________.
______ _____ ________ ____ _____ _____ ___ ____ __________.
_____ ________ _____ ____ ____ ________ ______ ____ ___ _____.
____ ____ _________ _____ ___ ______.
______ _____ __________ ______ ____ _______ __________ ______ ______.
_________ _____ _______ _______ ______ __________ _________ _________.
_______ ____ _________ ____ _________ ________ _____ ______ _______ ________.
IGNOU ACADEMY
  • Solved Assignments
  • Study Notes
  • Guess Papers
  • Question Papers
Skip in 10
Top
📞
Call Support Instant phone assistance IGNOU MVE 4 2017 - Briefly discuss the special provision in law related to biological pro | IGNOU Academy
🟢
WhatsApp Chat Fast live messaging
→
→